Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.17 USD | +1.24% | -6.19% | -11.09% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.09% | 544M | |
-2.73% | 103B | |
+1.56% | 95.28B | |
+1.46% | 22.15B | |
-16.57% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.04% | 16.05B | |
+5.27% | 13.68B | |
+33.88% | 12.17B |
- Stock Market
- Equities
- ORIC Stock
- News ORIC Pharmaceuticals, Inc.
- ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer